Guideline
Introduction to the EQIPD Quality System
To boost innovation by ensuring the generation of robust and reliable preclinical data, while being lean and effective, and not becoming a bureaucratic burden that could negatively impact the freedom to explore scientific questions.
While high risk of failure is an inherent part of developing innovative therapies, it can be reduced by adherence to evidence-based rigorous research practices. Supported through the European Union’s Innovative Medicines Initiative, the EQIPD consortium (Enhancing Quality In Preclinical Data) has developed a novel preclinical research quality system that can be applied in both public and private sectors and is free for anyone to use. EQIPD defines research quality as the extent to which research data are fit for their intended use. The essence of the EQIPD Quality System is a set of 18 core requirements that can be addressed flexibly, according to user-specific needs. EQIPD has also developed tools to support users in implementing the system. Building upon feedback from users and with continuous improvement, a sustainable EQIPD Quality System will ultimately serve the entire community of scientists conducting non-regulated preclinical research, by helping them generate reliable data that are fit for their intended use.
Reference of the resource
Anton Bespalov, Rene Bernard, Björn Gerlach, Christoph Emmerich, Malgorzata Pietraszek, Isabel A. Lefevre, Esmeralda Castaños-Vélez, et al.
“Introduction to the EQIPD Quality System” OSF Preprints (2020) doi:10.31219/osf.io/ng32b.
